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Abstract--Experimental acute lung injury mediated by reactive metabolites of oxy- 
gen can be inhibited by the antioxidant enzymes catalase and superoxide dismutase 
(SOD). However, the specific time interval during which these enzymes must be 
present in order to cause protection is not well defined. Using two experimental 
models of oxidant-dependent acute lung injury, one involving the intratracheal injec- 
tion of glucose, glucose oxidase, and lactoperoxidase and the other involving the 
intravenous injection of cobra venom factor (CVF), we investigated the effects of 
delaying antioxidant administration on the outcome of the inflammatory response. 
In both cases, the protective effects of catalase and SOD were rapidly attenuated 
when their administration was delayed for a short period of time. For example, intra- 
tracheal catalase resulted in 98% protection when given simultaneously with the 
glucose oxidase and lactoperoxidase, but only 13 % protection when the catalase was 
delayed 4 min. Likewise, in the CVF-induced lung injury model, intravenous cata- 
lase resulted in 40% protection when given simultaneously with the CVF, but only 
2 % protection when the catalase was delayed 20 min, even though the peak of the 
injury occurred hours after the initiation of the injury. A similar time dependence 
was seen with SOD. These results indicate that antioxidant therapy is required early 
in the course of oxygen radical-mediated acute lung injury for effective protection. 
INTRODUCTION 
Over the past few years, there have been a large number of studies that have 
illustrated the phlogistic potential of reactive oxygen radicals in the lung. In 
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humans the strongest evidence that oxidants are involved in lung injury comes 
from studies on patients with the adult respiratory distress syndrome (ARDS) 
or infant RDS. There is evidence of oxidant generation in the lungs of these 
patients as well as oxidative inactivation of alpha-l-PI (1-3). Other types of 
acute lung injury where reactive oxygen products are implicated include those 
caused by external agents that induce oxidant formation such as radiation (5), 
paraquat (5), endotoxin (6) as well as those agents that contain oxidants such 
as hyperoxia (7), nitrous dioxide (8), and oxidants present in cigarette smoke 
(9). 
There is a wealth of experimental data illustrating the toxic nature of oxi- 
dants. Oxidants are capable of injuring a variety of cells in culture (10-14). 
Oxidants also are capable of altering extracellular matrix components (15-20), 
inactivating proteolytic enzymes such as trypsin, chymotrypsin, and elastin as 
well as the major antiprotease, alpha-l-PI (21-23) and various other biologi- 
cally important mediators such as the chemotactic peptide C5a (24). 
In the isolated perfused lung system and in intact animals, enzymes and 
enzyme substrates such as xanthine-xanthine oxidase and glucose-glucose oxi- 
dase that directly produce superoxide anion (02-) and hydrogen peroxide (H202) 
cause acute lung injury that can be inhibited by SOD, catalase, and hydroxyl 
radical scavengers or iron chelators (25-26). Stimulated neutrophils or macro- 
phages have the same spectrum of injury. In the intact animals, acute lung 
injury induced by immune complexes, systemic complement activation, endo- 
toxin, and thermal injury seem to be largely mediated by the formation of oxi- 
dants by neutrophils and macrophages (16, 27-31). In the majority of these 
systems the addition of the antioxidants and/or iron chelators at the time of the 
initiation of the injury is very protective, with the bulk of the evidence favoring 
the concept that the hydroxyl radical (. OH) is primarily responsible for the 
initiation of the tissue injury (27, 29). 
In all of the in vivo studies, antioxidant inhibition of the lung injury has 
been accomplished by giving the inhibitors either before or during the initiation 
of the injury. No studies to date have looked at the time dependence of antiox- 
idant inhibition of acute lung injury. This is an especially relevant question in 
view of recent studies suggesting that oxidants are not primarily responsible for 
vascular as well as some types of glomerular injury (32). To assess this question 
we looked at the effects of delaying antioxidant therapy in two experimental 
models of oxygen radical dependent lung injury: glucose-glucose oxidase and 
CVF-induced lung injury. In the studies described below we provide evidence 
that antioxidant inhibition of the lung injury in these models is time dependent, 
with the inhibitors only able to fully protect if present at the beginning of the 
injury even though the full intensity of the injury occurs over several hours. 
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MATERIALS AND METHOD 
Animals and Reagents. Pathogen-free 300-to 350-gram male Long Evans rats were used in 
these studies. They were obtained from Charles River (Portage, Michigan) and were housed in a 
sterile laminar flow facility until the time of the experiments. 
Glucose oxidase (from Aspergillus niger), lactoperoxidase (from bovine milk), and glucose 
were all obtained from Sigma Chemical Co. (St. Louis, Missouri). The concentration of the glucose 
oxidase was 1200 units/ml, and the lactoperoxidase 340 units/ml. These stock solutions were diluted 
to an appropriate concentration in phosphate-buffered saline (pH 7.4). In vitro kinetic analysis of 
H202 production by the glucose oxidase was assessed spectrophotometrically (33). 
Cobra venom factor (CVF) was obtained from crude lyophilized Cobr (Naja naja) venom by 
ion-exchange chromatography and gel filtration (30). To assess the functional activity of the CVF, 
rats were injected intraperitoneally with 4 units of CVF and complement activity in these animals 
was assessed, The CVF injection resulted in complete abolition of CHso hemolytic activity(< 25 
CHs0 units/ml serum). 
Catalase and SOD were obtained from Enzon, Inc. (Piscataway, New Jersey). These enzymes 
were conjugated to polyethylene glycol (PEG) and are sterile preparations stored in membrane 
topped vials. For the in vivo experiments, the concentrations used of the PEG-SOD and PEG- 
catalase was 10,000 units/animal. 
Animal Models of Lung Injury The rats were anesthetized using ketamine anesthesia (War- 
ner Lambert, Morris Plains, New Jersey). In the CVF model of  lung injury, the rats were injected 
intravenously with 10 units of CVF in 0.5 ml of sterile saline or 0.5 ml of saline alone. In those 
animals where SOD and catalase were also used, 10,000 units of  either the PEG-SOD or PEG- 
catalase were injected intravenously with the CVF at time zero as well as 10 and 20 min later when 
the experiments were terminated at 30 min. When the injury was assessed at 2 h catalase and SOD 
were both used with the catalase given at time zero, 30 min and 1 h later, whereas, for the SOD 
studies the SOD was given at time zero and 30 rain later. In all cases the intensity of the lung 
injury was assessed by permeability changes and morphology as described below and the degree 
of lung injury compared to positive controls (no inhibitor) as well as antioxidants at time zero. The 
animals were sacrificed 30 min or 2 h later, depending on the study and the degree of lung injury 
quantitated as described below. 
In those studies were lung injury was induced by glucose, glucose oxidase, and lactoperox- 
idase, the following methods were used. The animals under ketamine anesthesia underwent a trach- 
eostomy and 1 mg of glucose, 50 units of  glucose oxidase and 1.7 units of lactoperoxidase were 
instilled the lung at the level of  the carina via a fine Teflon catheter in a volume of 200/zl. Following 
this the catheter is removed and the incision closed with silk suture. In those experiments where 
catalase was used, 10,000 units of  PEG-catalase was given at time zero with the other reactants or 
at the later time intervals as outlined in the experimental design. In order to ensure that the delayed 
catalase instillation was in the same site in the lungs as the enzyme substrate system, the catheter 
was left in place until after the catalase instillation. The animals were sacrificed after 4 h and the 
degree of lung injury assessed as described below. 
Quantitation of Lung Injury. The degree of tung injury was assessed by two techniques. 
The first technique involves the use of t25I rat albumin as a marker of permeability changes in the 
lung. The radiolabeled albumin is injected intravenously at the beginning of the experiment. At the 
time of sacrifice, 1 ml of  blood was collected from the vena cava and the amount of  radioactivity 
counted with a gamma counter. The heart and lung are then removed en bloc and 10 cc of sterile 
saline perfused through the right ventricle of  the heart to remove any radioactivity from the pul- 
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monary circulation. The lungs were then counted for total radioactivity and the ratio of this value 
compared to the radioactivity in 1 cc of blood is called the permeability index. This technique has 
been used for many years in our laboratory and in conjuctioon with morphology, has proven to be 
a sensitive indicator of lung injury (27, 30, 31). 
Correlative morphology studies also were used to assess the degree of lung injury. At least 
two animals per group were assessed this way. At the time of sacrifice the lungs were inflated with 
glutaraldehyde and at least two biopsies from each lobe of the lung were assessed by l-~m "'thick" 
sections embedded in Epon and stained with toluidine blue. From these thick sections at least five 
sections were selected for ultrastructural analysis. These biopsies were thin sectioned, and pro- 
cessed routinely for ultrastmctural analysis using a Phillips 401 transmission electron microscopy. 
Proteolytic Enzyme Assay. Proteolytic enzyme activity in lung lavage fluids was assessed 
using a modification of the procedure described by Anson (34). Briefly, lung lavage fluids were 
mixed with 0.5 ml of a 5 mg/ml solution of hemoglobin in PBS, pH 7.2, and incubated at 37~ 
for 18 h. At the end of the incubation period, the intact protein was precipitated with tricholoracetic 
acid (10% v/v, final concentration) and centrifuged at 2000 rpm for 20 min. The amount of protein 
fragments remaining in solution was then quantified using the Folin reagent and compared to a 
hemoglobin standard curve. In all experiments, hemoglobin was incubated with varying concen- 
trations of purified chymotrypsin. The amount of proteolytic activity in the lavage fluid was then 
estimated based on the chymotrypsin standard curve. 
R E S U L T S  
Time Dependence of Catalase Inhibition of Glucose-Glucose Oxidase-and 
Lactoperoxidase-Induced Lung Injury. The intratracheal instillation of glu- 
cose and glucose oxidase results in severe hemorrhagic lung injury that peaks 
in intensity at 4 -6  h. The addition of lactoperoxidase results in more severe 
injury, suggesting that hypochlorous acid (HOC1) is involved. Previous studies 
have demonstrated that if antioxidants, in particular catalase, are present at the 
initiation of the injury (time zero), there is a marked protective effect with over 
80% of the lung injury suppressed as compared to the positive controls (25). 
This is illustrated again in this study as shown in Figure 1, where the coinstil- 
lation of 10,000 units of PEG-catalase with the glucose, glucose oxidase, and 
lactoperoxidase provided virtually complete protection. For these studies we 
were interested primarily in determining the time dependence of the protective 
effect of catalase. To do this we simply delayed the catalase instillation into the 
lungs 0 .5-4  min after the instillation of the enzyme substrate system, taking 
care to leave the catheter in place to ensure that the catalase was infused into 
the same location. As illustrated in Figure 1, the ability of catalase to inhibit 
the lung injury was found to be markedly diminished over a short period of 
time. Delaying the catalase infusion only 0.5 min diminished the protective 
effect of the catalase by about 20%. This loss of protection by catalase was 
accentuated when catalase infusion was delayed further. For example, a delay 
of 2 min resulted in only 50% suppression from the lung injury, whereas at 4 
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Fig. 1. The ability of catalase to inhibit glucose oxidase-induced lung injury appears restricted to 
its being present at the initiation of the injury. An average of four rats were used at each time point. 
P < 0.05. 
min the protective effects of catalase are essentially lost. This loss of an inhib- 
itory effect of eatalase after 4 min is especially striking in view of the fact that 
in vitro significant H202 production occurs for greater than 45 min after the 
initiation of the reaction (Figure 2) and that the peak of the acute lung injury in 
this model does not occur until 4-6  h later. Thus, in summary, catalase suppres- 
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Fig. 2. In vitro kinetic production of H202 by 0.1 units of glucose oxidase illustrating a sustained 
production for over 45 min. 
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sion of glucose, glucose oxidase, and lactoperoxidase-induced lung injury 
appears to be strikingly time dependent, with catalase providing maximal pro- 
tection only at the initiation of the injury. 
Time Dependence of Antioxidant Inhibition of CVF-Induced Lung 
Injury. The intravenous injection of purified cobra venom factor (CVF) into 
rats results in systemic complement activation, neutrophil adherence to pul- 
monary capillary endothelial cells, and subsequent injury to these cells with 
edema, fibrin generation, and hemorrhage. The evidence that neutrophil-derived 
oxygen radicals are responsible for the injury in this model is based on dem- 
onstrating a marked protective effect when antioxidants or iron chelators were 
given at the same time or prior to the CVF (30, 31). In this model we again 
wanted to determine the time dependence of SOD and catalase inhibition similar 
to the studies done in the glucose, glucose oxidase, and lactoperoxidase-induced 
injury. In initial studies, as shown in Figure 3, we assessed the effect of delay- 
ing catalase administration on the degree of lung injury present 30 min after the 
CVF injection. When 10,000 units of PEG-catalase were given simultaneously 
with the CVF at time 0, there is a 45 % inhibition of the lung injury as measured 
by permeability changes. This degree of inhibition is similar to that previously 
described (30, 31). However, if the catalase instillation is delayed for a few 
minutes, this protective effect is lost rapidly. Thus, if catalase treatment is  
delayed until 10 min after the CVF injection, the degree of inhibition is only 
28 % as compared to the CVF-positive control animals. Even more striking is 
the fact that after 20 min catalase has virtually no suppressive effects, with only 
around 5 % inhibition of the injury. 
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Fig. 3. The ability of catalase to inhibit CVF lung injury is most pronounced if catalase is present 
at the initiation of the injury. The numbers of animals tested per time point was 5-10. P > 0.05. 
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inhibition in this model, we looked at time course studies of SOD and catalase 
inhibition over a longer period of time (2 h) in order to make sure that we were 
not missing a delayed effect of the antioxidants. As shown in Table 1, 10,000 
units of PEG-SOD when coadministered with the CVF causes a 41% inhibition 
of the lung injury as compared to the positive control animals. However, when 
SOD treatment is delayed until 30 rain after the CVF injection there is no evi- 
dence of any inhibition. Therefore, the protective effects of SOD in this model 
appear clearly to be time dependent. 
We also looked at the delayed effect of catalase instillation at this later 2-h 
time point. As also shown in Table 1, catalase given at time zero with the CVF 
causes a 43 % inhibition of the lung injury at 2 h. However, once again, if 
catalase administration is delayed, its protective effects are rapidly lost. For 
example, delaying the catalase administration for 30 min results in only an 8 % 
reduction in the degree of injury, whereas a delay of 60 min results in no pro- 
tection. Thus in the CVF model of lung injury, like the glucose-glucose oxidase 
and lactoperoxidase system, the inhibition by antioxidants clearly appears to be 
time dependent. 
Morphology Studies. Correlative morphology studies were performed in 
addition to the permeability studies. The morphologic alterations seen with 
delaying catalase infusion in the glucose, glucose oxidase, and lactoperoxidase 
model of lung injury are illustrated in Figure 4. As shown in Figure 4A, the 
instillation of this enzyme substrate system produces significant acute lung injury 
at 4 h with neutrophils present in alveolar capillaries, injury to endothelial and 
epithelial cells, edema with intraalveolar hemorrhage, and fibrin generation. If 
catalase is given at time 0 with the reactants, there is a marked protective effect 
Table 1. Time-Dependent Suppression of CVF-Induced Lung Injury by SOD and CATALASE 
at Two Hours 
Protection 
Experiment N Tissue injury " (%) Significance 
SOD Inhibition 
CVF alone (no SOD) 4 0.487 _+ 0.051 
CVF + SOD (time 0) 5 0.286 _+ 0.029 41 < .05 b 
CVF + SOD (30 rain later) 5 0.556 _+ 0.24 0 < .05' 
Catalase Inhibition 
CVF alone (no catalase) 2 0.635 _+ 0.16 
CVF + catalase (time 0) 4 0.378 ___ 0.087 43 < .05 ~' 
CVF + catalase (30 rain later) 2 0.59 +__ 0.014 8 < .05 " 
CVF + catalase (1 h later) 3 0.66 + 0.28 0 < .05  c 
aAssessed by radiolabeled permeability markers as detailed in Materials and Methods. 
hAs compared to positive control animals. 
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with neutrophils still present, but there is no evidence of injury (Figure 4B). By 
comparison, if catalase administration is delayed for 4 min (Figure 4C), much 
of the protective effect of catalase is lost as illustrated by edema and intraal- 
veolar hemorrhage. Much the same histologic picture is seen in the CVF lung 
injury model. As shown in Figure 5A, the intravenous injection of CVF induces 
neutrophil emigration into the lung and endothelial cell injury with subsequent 
edema and intraalveolar hemorrhage. If catalase is given at time 0 with the 
CVF, some decrease in the intensity of the lung injury is observed, although 
neutrophils are still present in alveolar capillaries (Figure 5B). However, delay- 
ing the catalase treatment for 20 min causes no apparent decrease in the lung 
injury (Figure 5C). Thus, the morphology studies correlate well with the perme- 
ability studies in confirming the time dependence of antioxidant inhibition of 
the lung injury in these two models. 
Protease Activity in Lung Lavage Fluids from Control and Glucose-Glu- 
cose Oxidase-Injured Rats. Lung lavage fluids were obtained from control and 
glucose-glucose oxidase -injured rats and assayed for proteolytic enzyme activ- 
ity as described in the Materials and Methods section. There was detectable 
activity in the lavage fluid from injured rats. Activity was seen as early as 2 h 
after injury. The highest amount detected (4 h after injury) was equivalent to 
activity of 30 ng of chymotrypsin (Table 2). Thus, measureable amounts of a 
second inflammatory mediator are present in the lungs after oxidant injury. 
DISCUSSION 
The results from this study provide evidence for the first time that antiox- 
idant inhibition of oxygen radical-mediated lung injury is sharply time depen- 
dent and that the antioxidants must be present at the time of the initiation of the 
injury in order to be effective. This sharply defined time limit of inhibition by 
the antioxidants is quite surprising in view of the fact that the full expression 
of the injury requires hours. One possible explanation for this loss of inhibition 
by the antioxidants over time would be that insufficient concentrations of these 
agents were used. While potentially this could explain our results, further pre- 
liminary studies suggest that this is not the case. In the CVF lung injury model 
increasing the dosage of catalase to 40 mg resulted in no additional protective 
effect (data not shown). Furthermore, the dosage of catalase and SOD used 
when given at time 0 was markedly protective, and therefore it seems unlikely 
that this loss of a protective effect of the antioxidants is dose related. 
Another possibility is that the oxygen radicals produce molecular damage 
very rapidly, even though the full extent of the injury at the cellular and tissue 
levels evolves over a period of several minutes to hours. In support of this is 


































































































































































































































































































































































































Time Dependent Oxidant Injury 
Table 2. Proteolytic Enzyme Activity in Lung Lavage Fluids from Control and 
Glucose-Glucose Oxidase-Injured Rats a 
519 
Solubilized gg, of Hemoglobin 
Group (X + SD) 
Buffer alone 6 _+ 3 
1 ng chymotrypsin 8 _ 1 
10 ng chymotrypsin 43 _+ 6 
100 ng chymotrypsin 195 +.% 7 
500/~1 of control lavage 7 + 2 
500/zl of lavage from G-GO injured rats 12 _+ 5 
aThe assay was carried out as described in the Materials and Methods section. The 
values shown represent averages _+ standard deviations based on four samples in a 
single experiment. The experiment was repeated three times with similar results. 
G-GO = glucose-glucose oxidase. 
responsible for the majority of injury in these models (27, 29). However, in 
both the glucose-glucose oxidase model and the CVF model, H202  is a key 
intermediate. Since this reactant has a relatively long half-life (7), and in the 
glucose oxidase system significant H202 production occurs for greater than 45 
rain, it is difficult to understand why even short delays in administration of 
eatalase would have such a profound effect on its ability to inhibit injury. Pos- 
sibly, the rapid diffusion of H202 across cell membranes sequesters this reactant 
from inhibitors added after a short delay. 
Presently available data cannot rule out this possibility. However, the data 
presented here is also consistent with the suggestion that while oxidants may 
be responsible for the initiation of tissue injury, they may not be solely respon- 
sible for the eventual severity and outcome of the inflammatory response. It 
may be that oxidant injury leads to tissue changes that increase the presence of 
other inflammatory mediators such as proteolytic enzymes. Likewise, cells 
injured by oxidants may become more susceptible to secondary effects of other 
inflammatory mediators. The demonstration of proteolytic enzyme activity in 
the lavage fluid of rats after experimental injury with glucose-glucose oxidase 
is supportive of this. Furthermore, we recently demonstrated in an in vitro model 
that rat pulmonary artery endothelial cells exposed to H202 became sensitive to 
injury by a variety of proteolytic enzymes including trypsin, chymotrypsin, 
elastase, and cathepsin G, whereas control endothelial cells were much less 
sensitive to these proteases (37). It is of interest that in the in vitro model, the 
injurious effects of H 2 0  2 occurred rapidly upon exposure of the cells to the 
oxidant. Treatment of the cells with catalase 1 h after exposure to H 2 0  2 failed 
completely to prevent injury. In contrast, the proteolytic enzyme-mediated injury 
could be largely attenuated with appropriate inhibitors as long as 4 h after expo- 
sure. Thus, these in vitro observations support the concept that oxidants and 
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proteolytic enzymes may act synergistically to produce the tissue injury that is 
characteristic of inflammation. This hypothesis is supported by studies from 
other laboratories where proteases are present at sites of oxidant injury in vivo 
(38, 39) and proteases and oxidants act synergistically to increase injury in the 
isolated perfused lung system (40). It should also be noted that other agents 
including cytokines (41), cationic proteins (42), and lysophosphatides (42) have 
also been shown in in vitro models to potentiate oxidant-induced cytotoxicity. 
Taken together with the data presented here, it appears reasonable to consider 
the interactions between various inflammatory mediators as determinants of the 
severity of tissue injury rather than the effects of individual mediators alone. 
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